Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2009

Feb 26, 2009

30339_dirs_2009-02-26_dae1cb5f-8356-4a87-84d4-52f63658f10b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2009-02-24

Reporting Person: GAILEY JOHN R (VP, Gen. Counsel & Sec.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-02-26 Common Stock A 2143 $32.09 Acquired 8605.2204 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-02-24 Stock Option (Right to Buy) $32.09 A 13000 Acquired 2019-02-24 Common Stock (13000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 20408.7547 Direct
Common Stock 676.8182 Indirect

Footnotes

F1: Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2006 that have vested for performance period V.